Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.3390/md18110570

http://scihub22266oqcxt.onion/10.3390/md18110570
suck pdf from google scholar
33228163!7699502!33228163
unlimited free pdf from europmc33228163    free
PDF from PMC    free
html from PMC    free

Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=33228163&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215

suck abstract from ncbi

pmid33228163      Mar+Drugs 2020 ; 18 (11): ?
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Molluscan Compounds Provide Drug Leads for the Treatment and Prevention of Respiratory Disease #MMPMID33228163
  • Summer K; Browne J; Liu L; Benkendorff K
  • Mar Drugs 2020[Nov]; 18 (11): ? PMID33228163show ga
  • Respiratory diseases place an immense burden on global health and there is a compelling need for the discovery of new compounds for therapeutic development. Here, we identify research priorities by critically reviewing pre-clinical and clinical studies using extracts and compounds derived from molluscs, as well as traditional molluscan medicines, used in the treatment of respiratory diseases. We reviewed 97 biomedical articles demonstrating the anti-inflammatory, antimicrobial, anticancer, and immunomodulatory properties of >320 molluscan extracts/compounds with direct relevance to respiratory disease, in addition to others with promising bioactivities yet to be tested in the respiratory context. Of pertinent interest are compounds demonstrating biofilm inhibition/disruption and antiviral activity, as well as synergism with approved antimicrobial and chemotherapeutic agents. At least 100 traditional medicines, incorporating over 300 different mollusc species, have been used to treat respiratory-related illness in cultures worldwide for thousands of years. These medicines provide useful clues for the discovery of bioactive components that likely underpin their continued use. There is particular incentive for investigations into anti-inflammatory compounds, given the extensive application of molluscan traditional medicines for symptoms of inflammation, and shells, which are the principal molluscan product used in these preparations. Overall, there is a need to target research toward specific respiratory disease-related hypotheses, purify bioactive compounds and elucidate their chemical structures, and develop an evidence base for the integration of quality-controlled traditional medicines.
  • |Animals[MESH]
  • |Anti-Inflammatory Agents/*isolation & purification/pharmacology[MESH]
  • |Antiviral Agents/isolation & purification/pharmacology[MESH]
  • |COVID-19[MESH]
  • |Coronavirus Infections/complications[MESH]
  • |Drug Discovery[MESH]
  • |Humans[MESH]
  • |Inflammation/drug therapy[MESH]
  • |Medicine, Traditional[MESH]
  • |Mollusca/*chemistry[MESH]
  • |Pandemics[MESH]
  • |Pneumonia, Viral/complications[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box